يعرض 1 - 10 نتائج من 48 نتيجة بحث عن '"disease extent"', وقت الاستعلام: 1.38s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
  6. 6
    دورية أكاديمية

    المصدر: Diagnostic radiology and radiotherapy; № 4 (2019); 49-56 ; Лучевая диагностика и терапия; № 4 (2019); 49-56 ; 2079-5343 ; 10.22328/2079-5343-2019-4

    وصف الملف: application/pdf

    العلاقة: https://radiag.bmoc-spb.ru/jour/article/view/454/370Test; Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C. F., Karstens J. H., Liersch T., Schmidberger H., Raab R., German Rectal Canc Study G. Preoperative versus postoperative chemoradiotherapy for rectal cancer // New England Journal of Medicine. 2004. Vol. 351, No. 17. P. 1731-1740. DOI:10.1056/NEJMoa040694.; Heald R.J. New approach to rectal-cancer // British Journal of Hospital Medicine. 1979. Vol. 22, No. 3. P. 277-281. PMID: 391315.; Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., Putter H., Steup W.H., Wiggers T., Rutten H.J.T., Pahlman L., Glimelius B., van Krieken J., Leer J.W.H., van de Velde C.J.H., Dutch Colorectal Canc G. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer // New England Journal of Medicine. 2001. Vol. 345, No. 9. P. 638-646. DOI:10.1056/NEJMoa010580.; Tudyka V., Blomqvist L., Beets-Tan R.G.H., Boelens P.G., Valentini V., van de Velde C.J., Dieguez A., Brown G. EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: The radiology experts review // Ejso. 2014. Vol. 40, No. 4. P. 469-475. DOI:10.1016/j.ejso.2013.10.029.; Балясникова С., Дронова Е., Лукьянченко А., Долгушин Б., Барсуков Ю., Царюк В., Полыновский А., Кузьмичев Д. Возможности стандартных режимов магнитно-резонансной томографии совместно с диффузионно-взвешенной магнитно-резонансной томографией в оценке местной распространенности рака прямой кишки // Онкологическая колопроктология. 2013. T. 3. № 1. C. 17-28. DOI:10.17650/2220-3478-2013-0-1-19-30.; Bipat S., Glas A.S., Slors F.J.M., Zwinderman A.H., Bossuyt P.M.M., Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging — A meta-analysis // Radiology. 2004. Vol. 232, No. 3. P. 773-783. DOI:10.1148/radiol.2323031368.; Smith N.J., Barbachano Y., Norman A.R., Swift R.I., Abulafi A.M., Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer // British Journal of Surgery. 2008. Vol. 95, No. 2. P. 229-236. DOI:10.1002/bjs.5917.; Sclafani F., Brown G. Extramural Venous Invasion (EMVI) and Tumour Regression Grading (TRG) as Potential Prognostic Factors for Risk Stratification and Treatment Decision in Rectal Cancer // Current Colorectal Cancer Reports. 2016. Vol. 12, No. 3. P. 130-140. DOI:10.1007/s11888-016-0319-4.; Sclafani F., Brown G., Cunningham D., Wotherspoon A., Tait D., Peckitt C., Evans J., Yu S., Teixeira Mendes L. S., Tabernero J., Glimelius B., Cervantes A., Thomas J., Begum R., Oates J., Chau I. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradio-therapy in MRI-defined, locally advanced rectal cancer // Annals of Oncology. 2016. Vol. 27, No. 8. P. 1557-1565. DOI:10.1093/annonc/mdw215.; Sclafani F., Chau I. Timing of Therapies in the Multidisciplinary Treatment of Locally Advanced Rectal Cancer: available Evidence and Implications for Routine Practice // Seminars in Radiation Oncology. 2016. Vol. 26, No. 3. P. 176-185. DOI:10.1016/j.semradonc.2016.02.008.; Van der Paardt M.P., Zagers M.B., Beets-Tan R.G.H., Stoker J., Bipat S. Patients Who Undergo Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Restaged by Using Diagnostic MR Imaging: A Systematic Review and Meta-Analysis // Radiology. 2013. Vol. 269, No. 1. P. 101-112. DOI:10.1148/radiol.13122833.; Zhao R.-S., Wang H., Zhou Z.-Y., Zhou Q., Mulholland M.W. Restaging of Locally Advanced Rectal Cancer With Magnetic Resonance Imaging and Endoluminal Ultrasound After Preoperative Chemoradiotherapy: A Systemic Review and Meta-analysis // Diseases of the Colon & Rectum. 2014. Vol. 57, No. 3. P. 388-395. DOI:10.1097/DCR.0000000000000022.; Memon S., Lynch A.C., Bressel M., Wise A.G., Heriot A.G. Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy // Colorectal Disease. 2015. Vol. 17, No. 9. P. 748-761. DOI: 10.111l/codi.12976.; Van den Broek J.J., van der Wolf F.S.W., Lahaye M.J., Heijnen L.A., Meischl C., Heitbrink M.A., Schreurs W.H. Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation // Diseases of the Colon & Rectum. 2017. Vol. 60, No. 3. P. 274-283. DOI:10.1097/DCR.0000000000000743.; Patel U.B., Taylor F., Blomqvist L., George C., Evans H., Tekkis P., Quirke P., Sebag-Montefiore D., Moran B., Heald R., Guthrie A., Bees N., Swift I., Pennert K., Brown G. Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience // Journal of Clinical Oncology. 2011. Vol. 29, No. 28. P. 3753-3760. DOI:10.1200/JC0.2011.34.9068.; Fornell-Perez R., Perez-Alonso E., Aleman-Flores P., Lozano-Rodriguez A., Loro-Ferrer J. F. Nodal staging in the rectal cancer follow-up MRI after chemoradiotherapy: use of morphology, size, and diffusion criteria // Clinical radiology. 2019. DOI:10.1016/j.crad.2019.08.003.; Chen Y., Yang X., Lu B., Xiao X., Zhuang X., Yu S. Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer // Zhonghua wei chang wai ke za zhi=Chinese journal of gastrointestinal surgery. 2018. Vol. 21, No. 7. P. 786-792. PMID: 30051447.; Kreis M.E., Ruppert R., Kube R., Strassburg J., Lewin A., Baral J., Maurer C.A., Sauer J., Winde G., Thomasmeyer R., Stelzner S., Bambauer C., Scheunemann S., Faedrich A., Junginger T., Hermanek P., Merkel S., group O. MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial // Annals of surgical oncology. 2019. DOI:10.1245/s10434-019-07696-y.; Shihab O.C., How P., West N., George C., Patel U., Quirke P., Heald R.J., Moran B.J., Brown G. Can a Novel MRI Staging System for Low Rectal Cancer Aid Surgical Planning? // Diseases of the Colon & Rectum. 2011. Vol. 54, No. 10. P. 1260-1264. DOI:10.1097/DCR.0b013e31822abd78.; Bokey E.L., Chapuis P.H., Dent O.F., Newland R.C., Koorey S.G., Zelas P.J., Stewart P.J. Factors affecting survival after excision of the rectum for cancer — a multivariate analysis // Diseases of the Colon & Rectum. 1997. Vol. 40, No. 1. P. 3-10. DOI:10.1007/bf02055674.; Freedman L.S., Macaskill P., Smith A. N. Multivariate-analysis of prognostic factors for operable rectal-cancer // Lancet. 1984. Vol. 2, No. 8405. P. 733736. DOI:10.1016/s0140-6736(84)92636-9.; Smith N.J., Shihab O., Arnaout A., Swift R.I., Brown G. MRI for Detection of Extramural Vascular Invasion in Rectal Cancer // American Journal of Roentgenology. 2008. Vol. 191, No. 5. P. 1517-1522. DOI:10.2214/AJR.08.1298.; Kim Y.E., Park M.S., Hong H.S., Kang C.M., Choi J.Y., Lim J.S., Lee W.J., Kim M.J., Kim K.W. Effects of Neoadjuvant Combined Chemotherapy and Radiation Therapy on the CT Evaluation of Resectability and Staging in Patients with Pancreatic Head Cancer // Radiology. 2009. Vol. 250, No. 3. P. 758-765. DOI:10.1148/radiol.2502080501.; Messenger D.E., Driman D.K., Kirsch R. Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome // Human Pathology. 2012. Vol. 43, No. 7. P. 965-973. DOI:10.1016/j.humpath.2011.11.015.; Bae J.S., Kim S.H., Hur B.Y., Chang W., Park J., Park H.E., Kim J.H., Kang H.-J., Yu M.H., Han J.K. Prognostic value of MRI in assessing extramural № 4 (10) 2019 venous invasion in rectal cancer: multi-readers' diagnostic performance // European Radiology. 2019. Vol. 29, No. 8. P. 4379-4388. DOI:10.1007/s00330-018-5926-9.; Hotker A.M., Tarlinton L., Mazaheri Y., Woo K.M., Gonen M., Saltz L.B., Goodman K.A., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters // European Radiology. 2016. Vol. 26, No. 12. P. 4303-4312. DOI:10.1007/s00330-016-4283-9.; Lambregts D.M.J., Rao S.X., Sassen S., Martens M.H., Heijnen L.A., Buijsen J., Sosef M., Beets G.L., Vliegen R.A., Beets-Tan R.G.H. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer A Bi-institutional Validation Study // Annals of Surgery. 2015. Vol. 262, No. 6. P. 1034-1039. DOI:10.1097/SLA.0000000000000909.; Sclafani F., Brown G., Cunningham D., Wotherspoon A., Mendes L.S.T., Balyasnikova S., Evans J., Peckitt C., Begum R., Tait D., Tabernero J., Glimelius B., Rosello S., Thomas J., Oates J., Chau I. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer // British Journal of Cancer. 2017. Vol. 117, No. 10. P. 1478-1485. DOI:10.1038/bjc.2017.320.; Nahas S.C., Nahas C.S.R., Cama G.M., de Azambuja R.L., Horvat N., Marques C.F.S., Menezes M.R., Ribeiro U., Cecconello I. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer // Abdominal Radiology. 2019. Vol. 44, No. 11. P. 3632-3640. DOI:10.1007/s00261-019-01894-8.; Sloothaak D.A.M., Geijsen D.E., van Leersum N.J., Punt C.J.A., Buskens C.J., Bemelman W.A., Tanis P.J., Dutch Surgical Colorectal A. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer // British Journal of Surgery. 2013. Vol. 100, No. 7. P. 9331108. DOI:10.1002/bjs.9112.; Probst C.P., Becerra A.Z., Aquina C. T., Tejani M.A., Wexner S.D., Garcia-Aguilar J., Remzi F.H., Dietz D.W., Monson J.R.T., Fleming F.J. Consortium Optimizing Surgical T. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation // Journal of the American College of Surgeons. 2015. Vol. 221, No. 2. P. 430-440. DOI:10.1016/j.jamcollsurg.2015.04.010.; Sun Z., Adam M.A., Kim J., Shenoi M., Migaly J., Mantyh C.R. Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer // Journal of the American College of Surgeons. 2016. Vol. 222, No. 4. P. 367-374. DOI:10.1016/j.jamcollsurg.2015.12.017.; Bhoday J., Smith F., Siddiqui M.R., Balyasnikova S., Swift R.I., Perez R., Habr-Gama A., Brown G. Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy // Diseases of the Colon & Rectum. 2016. Vol. 59, No. 10. P. 925-933. DOI:10.1097/DCR.0000000000000667.; Siddiqui M.R.S., Bhoday J., Battersby N.J., Chand M., West N.P., Abulafi A.-M., Tekkis P.P., Brown G. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales // World Journal of Gastroenterology. 2016. Vol. 22, No. 37. P. 8414-8434. DOI:10.3748/wjg.v22.i37.8414.; Peacock O., Chang G.J. «Watch and Wait» for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer // Minerva chirurgica. 2019. DOI:10.23736/S0026-4733.19.08184-7.; https://radiag.bmoc-spb.ru/jour/article/view/454Test

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Diagnostic radiology and radiotherapy; № 2 (2019); 102-107 ; Лучевая диагностика и терапия; № 2 (2019); 102-107 ; 2079-5343 ; 10.22328/2079-5343-2019-2

    وصف الملف: application/pdf

    العلاقة: https://radiag.bmoc-spb.ru/jour/article/view/420/351Test; Harji D.P., Sagar P.M. Advancing the surgical treatment of locally recurrent rectal cancer // British Journal of Surgery. 2012. Vol. 99, No. 9. Р. 1169–1171. DOI:10.1002/bjs.8879.; Sagar P.M., Pemberton J.H. Surgical management of locally recurrent rectal cancer // British Journal of Surgery. 1996. Vol. 83, No. 3. Р. 293–304.; Siddiqui M.R.S., Simillis C., Hunter C., Chand M., Bhoday J., Garant A., Vuong T., Artho G., Rasheed S., Tekkis P., Abulafi A., Brown G. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases // British Journal of Cancer. 2017. Vol. 116, No. 12. Р. 1513–1519. DOI:10.1038/bjc.2017.99.; Карачун А.М., Петров А.С. Рак среднеампулярного отдела прямой кишки — какую операцию выбрать? — Низкая передняя резекция прямой кишки // Злокачественные опухоли. 2013. T. 2, № 2 (6). C. 23–32. DOI:10.18027/2224-5057-2013-2-23-32.; Rodel C., Sauer R., Fietkau R. The Role of Magnetic Resonance Imaging to Select Patients for Preoperative Treatment in Rectal Cancer // Strahlentherapie Und Onkologie. 2009. Vol. 185, No. 8. Р. 488–492. DOI:10.1007/s00066-009-2043-3.; Al-Sukhni E., Milot L., Fruitman M., Beyene J., Victor J. C., Schmocker S., Brown G., McLeod R., Kennedy E. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis // Annals of Surgical Oncology. 2012. Vol. 19, No. 7. Р. 2212–2223. DOI:10.1245/s10434-011-2210-5.; Karatag O., Karatag G.Y., Ozkurt H., Degirmenci H.K., Avlanmis O., Basak M., Baykan A. The ability of phased-array MRI in preoperative staging of primary rectal cancer: correlation with histopathological results // Diagnostic and Interventional Radiology. 2012. Vol. 18, No. 1. Р. 20–26. DOI:10.4261/1305-3825.DIR.3394-10.2.; Kim S.H., Lee J.M., Park H.S., Eun H.W., Han J.K., Choi B.I. Accuracy of MRI for Predicting the Circumferential Resection Margin, Mesorectal Fascia Invasion, and Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer // Journal of Magnetic Resonance Imaging. 2009. Vol. 29, No. 5. Р. 1093–1101. DOI:10.1002/jmri.21742.; Beets-Tan R.G.H., Lambregts D.M.J., Maas M., Bipat S., Barbaro B., Curvo-Semedo L., Fenlon H.M., Gollub M.J., Gourtsoyianni S., Halligan S., Hoeffel C., Kim S.H., Laghi A., Maier A., Rafaelsen S.R., Stoker J., Taylor S.A., Torkzad M.R., Blomqvist L. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting // European Radiology. 2018. Vol. 28, No. 4. Р. 1465–1475. DOI:10.1007/s00330-017-5026-2.; Nougaret S., Reinhold C., Mikhael H. W., Rouanet P., Bibeau F., Brown G. The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the «DISTANCE»? // Radiology. 2013. Vol. 268, № 2. C. 329–343. DOI:10.1148/radiol.13121361.; Patel U.B., Taylor F., Blomqvist L., George C., Evans H., Tekkis P., Quirke P., Sebag-Montefiore D., Moran B., Heald R., Guthrie A., Bees N., Swift I., Pennert K., Brown G. Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience // Journal of Clinical Oncology. 2011. Vol. 29, No. 28. Р. 3753–3760. DOI:10.1200/JCO.2011.34.9068.; Laghi A., Ferri M., Catalano C., Baeli I., Iannaccone R., Iafrate F., Ziparo V., Passariello R. Local staging of rectal cancer with MRI using a phased array body coil // Abdominal Imaging. 2002. Vol. 27, No. 4. Р. 425–431. DOI:10.1107/s00261-001-0123-7.; Gualdi G.F., Casciani E., Guadalaxara A., d’Orta C., Polettini E., Pappalardo G. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging — Comparison with histologic findings // Diseases of the Colon & Rectum. 2000. Vol. 43, No. 3. Р. 338–345.; Samdani T., Garcia-Aguilar J. Imaging in Rectal Cancer Magnetic Resonance Imaging Versus Endorectal Ultrasonography // Surgical Oncology Clinics of North America. 2014. Vol. 23, No. 1. Р. 59–77. DOI:10.1016/j.soc.2013.09.011.; Burdan F., Sudol-Szopinska I., Staroslawska E., Kolodziejczak M., Klepacz R., Mocarska A., Caban M., Zelazowska-Cieslinska I., Szumilo J. Magnetic resonance imaging and endorectal ultrasound for diagnosis of rectal lesions // European Journal of Medical Research. 2015. Vol. 20. DOI:10.1186/s40001-014-0078-0.; Piippo U., Paakko E., Makinen M., Makela J. Local staging of rectal cancer using the black lumen magnetic resonance imaging technique // Scandinavian Journal of Surgery. 2008. Vol. 97, No. 3. Р. 237–242. DOI:10.1177/145749690809700306.; Mulla M., Deb R., Singh R. MRI in T staging of rectal cancer: How effective is it? // The Indian journal of radiology & imaging. 2010. Vol. 20, No. 2. C. 118–121. DOI:10.4103/0971-3026.63055.; Brown G., Radcliffe A.G., Newcombe R.G., Dallimore N.S., Bourne M.W., Williams G.T. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging // British Journal of Surgery. 2003. Vol. 90, No. 3. Р. 355–364. DOI:10.1002/bjs.4034.; Blomqvist L., Glimelius B. The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers // Acta Oncologica. 2000. Vol. 47, No. 1. Р. 5–8. DOI:10.1080/02841860701802585.; Vliegen R.F.A., Beets G.L., von Meyenfeldt M.F., Kessels A.G.H., Lemaire E., van Engelshoven J.M.A., Beets-Tan R.G.H. Rectal cancer: MR Imaging in local staging — Is gadolinium-based contrast material helpful? // Radiology. 2005. Vol. 234, No. 1. Р. 179–188. DOI:10.1148/radiol.2341031403.; Jao S.Y., Yang B.Y., Weng H.H., Yeh C.H., Lee L.W. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer // Colorectal Disease. 2010. Vol. 12, No. 11. Р. 1139–1148. DOI:10.1111/j.1463-1318.2009.01959.x.; Okizuka H., Sugimura K., Yoshizako T., Kaji Y., Wada A. Rectal carcinoma: Prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging // Jmri-Journal of Magnetic Resonance Imaging. 1996. Vol. 6, No. 3. Р. 465–471.; Lim J.S., Kim D., Baek S.-E., Myoung S., Choi J., Shin S.J., Kim M.-J., Kim N.K., Suh J., Kim K. W., Keum K.C. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer // European Radiology. 2012. Vol. 22, No. 8. Р. 1693–1700. DOI:10.1007/s00330-012-2416-3.; Yeo D.M., Oh S.N., Choi M.H., Lee S.H., Lee M.A., Jung S.E. Histogram Analysis of Perfusion Parameters from Dynamic Contrast-Enhanced MR Imaging with Tumor Characteristics and Therapeutic Response in Locally Advanced Rectal Cancer // Biomed Research International. 2018. DOI:10.1155/2018/3724393.; Intven M., Reerink O., Philippens M.E.P. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation // Journal of Magnetic Resonance Imaging. 2015. Vol. 41, No. 6. Р. 1646–1653. DOI:10.1002/jmri.24718.; Lu Z.H., Hu C.H., Qian W.X., Cao W.H. Preoperative diffusionweighted imaging value of rectal cancer: preoperative T staging and correlations with histological T stage // Clinical Imaging. 2016. Vol. 40, No. 3. Р. 563–568. DOI:10.1016/j.clinimag.2015.12.006.; Van Heeswijk M.M., Lambregts D.M.J., Palm W.M., Hendriks B.M.F., Maas M., Beets G.L., Beets-Tan R.G.H. DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status? // American Journal of Roentgenology. 2017. Vol. 208, No. 3. Р. W79–W84. DOI:10.2214/AJR.16.17117.; Lambregts D.M.J., Vandecaveye V., Barbaro B., Bakers F.C.H., Lambrecht M., Maas M., Haustermans K., Valentini V., Beets G.L., Beets-Tan R.G.H. Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study // Annals of Surgical Oncology. 2011. Vol. 18, No. 8. Р. 2224–2231. DOI:10.1245/s10434-011-1607-5.; Foti P.V., Privitera G., Piana S., Palmucci S., Spatola C., Bevilacqua R., Raffaele L., Salamone V., Caltabiano R., Magro G., Destri G.L., Milone P., Ettorre G.C. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemoradiotherapy // European Journal of Radiology Open. 2016. Vol. 3. Р. 145–152. DOI:10.1016/j.ejro.2016.06.003.; Wu L.M., Zhu J., Hu J.I., Yin Y., Gu H.Y., Hua J., Chen J., Xu J.R. Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? // International Journal of Colorectal Disease. 2013. Vol. 28, No. 9. Р. 1225–1238. DOI:10.1007/s00384-013-1676-y.; Kim S.H., Lee J.M., Lee M.W., Kim G.H., Han J.K., Choi B.I. Sonography transmission gel as endorectal contrast agent for tumor visualization in rectal cancer // American Journal of Roentgenology. 2008. Vol. 191, No. 1. Р. 186–189. DOI:10.2214/AJR.07.3067.; https://radiag.bmoc-spb.ru/jour/article/view/420Test

  10. 10
    دورية أكاديمية

    المصدر: Medical Visualization; № 2 (2019); 7-26 ; Медицинская визуализация; № 2 (2019); 7-26 ; 2408-9516 ; 1607-0763

    وصف الملف: application/pdf

    العلاقة: https://medvis.vidar.ru/jour/article/view/766/543Test; Glynne-Jones R., Wyrwicz L., Tiret E., Brown G., Rodel C., Cervantes A., Arnold D., ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl. 4): 22–40. http://doi.org/10.1093/annonc/mdx224Test.; American Cancer Society. Cancer Facts & Figures. 2017. Available at: https://www.cancer.org/content/damTest/ cancer-org/research/cancer-facts-and-statistics/ annual-cancer-facts-and-figures/2017/cancer-factsand-figures-2017.pdf (accessed August 12, 2018).; Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2011; 22 (3, Прил. 1) (85): 1–170.; Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 250 с.; Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 250 с.; Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc. Royal Soc. Med. 1974; 67 (6): 451–457.; Kang H., O'Connell J.B., Leonardi M.J., Maggard M.A., McGory M.L., Ko C.Y. Rare tumors of the colon and rectum: a national review. Int. J. Colorectal Dis. 2007; 22 (2): 183–189.; Union for International Cancer Control (UICC). Available at: https://www.hoofdhalskanker.info/wpavl/wp-contentTest/ uploads/TNM-Classification-of-Malignant-Tumours-8thedition.pdf. (accessed August 12, 2018).; Balyasnikova S., Brown G. Imaging Advances in Colorectal Cancer. Curr. Colorectal Cancer Rep. 2016; 12 (3): 162–169. http://doi.org/10.1007/s11888-016-0321-xTest.; Beets-Tan R.G.H., Lambregts D.M.J., Maas M., Bipat S., Barbaro B., Curvo-Semedo L., Fenlon H.M., Gollub M.J., Gourtsoyianni S., Halligan S., Hoeffel C., Kim S.H., Laghi A., Maier A., Rafaelsen S.R., Stoker J., Taylor S.A., Torkzad M.R., Blomqvist L. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastro intestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol. 2018; 28 (4): 1465–1475. http://doi.org/10.1007/s00330-017-5026-2Test.; Peschaud F., Benoist S., Julie C., Penna C., Nordlinger B. The mesorectum: an anatomical entity that is difficult to evaluate with MRI. Morphologie: bulletin de l'Association des anatomistes. 2005; 89 (286): 126–130.; Rodel C., Sauer R., Fietkau R. The Role of Magnetic Resonance Imaging to Select Patients for Preoperative Treatment in Rectal Cancer. Strahlentherapie Onkol. 2009; 185 (8): 488–492. http://doi.org/10.1007/s00066-009-2043-3Test.; Al-Sukhni E., Milot L., Fruitman M., Beyene J., Victor J.C., Schmocker S., Brown G., McLeod R., Kennedy E. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. Ann. Surg. Oncol. 2012; 19 (7): 2212–2223. http://doi.org/10.1245/s10434-011-2210-5Test.; Karatag O., Karatag G.Y., Ozkurt H., Degirmenci H.K., Avlanmis O., Basak M., Baykan A. The ability of phasedarray MRI in preoperative staging of primary rectal cancer: correlation with histopathological results. Diagn. Interv. Radiol. 2012; 18 (1): 20–26. http://doi.org/10.4261/1305-3825.DIR.3394-10.2Test.; Kim S.H., Lee J.M., Park H.S., Eun H.W., Han J.K., Choi B.I. Accuracy of MRI for Predicting the Circumferential Resection Margin, Mesorectal Fascia Invasion, and Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. J. Magn. Reson. Imaging. 2009; 29 (5): 1093–1101. http://doi.org/10.1002/jmri.21742Test.; Koh D.M., Brown G., Temple L., Blake H., Raja A., Toomey P., Bett N., Farhat S., Norman A.R., Daniels I., Husband J.E. Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur. Radiol. 2005; 15 (8): 1650–1657. http://doi.org/10.1007/s00330-005-2751-8Test.; Nougaret S., Reinhold C., Mikhael H.W., Rouanet P., Bibeau F., Brown G. The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the “DISTANCE”? Radiology. 2013; 268 (2): 329–343. http://doi.org/10.1148/radiol.13121361Test.; Patel U.B., Taylor F., Blomqvist L., George C., Evans H., Tekkis P., Quirke P., Sebag-Montefiore D., Moran B., Heald R., Guthrie A., Bees N., Swift I., Pennert K., Brown G. Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. J. Clin. Oncol. 2011; 29 (28): 3753–3760. http://doi.org/10.1200/JCO.2011.34.9068Test.; Piippo U., Paakko E., Makinen M., Makela J. Local staging of rectal cancer using the black lumen magnetic resonance imaging technique. Scand. J. Surg. 2008; 97 (3): 237–242. http://doi.org/10.1177/145749690809700306Test.; Mulla M., Deb R., Singh R. MRI in T staging of rectal cancer: How effective is it? Indian J. Radiol. Imaging. 2010; 20 (2): 118–121. http://doi.org/10.4103/0971-3026.63055Test.; Vliegen R.F.A., Beets G.L., von Meyenfeldt M.F., Kessels A.G.H., Lemaire E., van Engelshoven J.M.A., Beets-Tan R.G.H. Rectal cancer: MR Imaging in local staging – Is gadolinium-based contrast material helpful? Radiology. 2005; 234 (1): 179–188. http://doi.org/10.1148/radiol.2341031403Test.; Jao S.Y., Yang B.Y., Weng H.H., Yeh C.H., Lee L.W. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Colorectal Dis. 2010; 12 (11): 1139–1148. http://doi.org/10.1111/j.1463-1318.2009.01959.xTest.; Lambregts D.M.J., Vandecaveye V., Barbaro B., Bakers F.C.H., Lambrecht M., Maas M., Hauster mans K., Valentini V., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann. Surg. Oncol. 2011; 18 (8): 2224–2231. http://doi.org/10.1245/s10434-011-1607-5Test.; Foti P.V., Privitera G., Piana S., Palmucci S., Spatola C., Bevilacqua R., Raffaele L., Salamone V., Caltabiano R., Magro G., Destri G.L., Milone P., Ettorre G.C. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemoradiotherapy. Eur. J. Radiol. Open. 2016; 3: 145–152. http://doi.org/10.1016/j.ejro.2016.06.003Test.; Brown G. Thin section MRI in multidisciplinary preoperative decision making for patients with rectal cancer. Br. J. Radiol. 2005; 78: 117–127. http://doi.org/10.1259/bjr/15128198Test.; Dukes C.E. The classification of cancer of the rectum. The Journal of Pathology and Bacteriology. 1932; 35 (3): 323–332.; Brown G. Staging rectal cancer: endoscopic ultrasound and pelvic MRI. Cancer Imaging. 2008; 8 (A): 43–45. http://doi.org/10.1102/1470-7330.2008.9008Test.; Kikuchi R., Takano M., Takagi K., Fujimoto N., Nozaki R., Fujiyoshi T., Uchida Y. Management of early invasive colorectal-cancer – risk of recurrence and clinical guidelines. Dis. Colon. Rectum. 1995; 38 (12): 1286–1295.; Puli S.R., Bechtold M.L., Reddy J.B.K., Choudhary A., Antillon M.R. Can Endoscopic Ultrasound Predict Early Rectal Cancers That Can Be Resected Endoscopically? A Meta-Analysis and Systematic Review. Dig. Dis. Sci. 2010; 55 (5): 1221–1229. http://doi.org/10.1007/s10620-009-0862-9Test.; Balyasnikova S., Read J., Wotherspoon A., Rasheed S., Tekkis P., Tait D., Cunningham D., Brown G. Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer. BMJ Open Gastroenterol. 2017; 4 (1): e000151. http://doi.org/10.1136/bmjgast-2017-000151Test.; Brown G., Daniels I.R., Heald R.J., Quirke P., Blomqvist L., Sebag-Montefiore D., Moran B.J., Holm T., Strassbourg J., Peppercorn P.D., Fisher S.E., Mason B., Grp M.S. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br. Med. J. 2006; 333 (7572): 779–782. http://doi.org/10.1136/bmj.38937.646400.55Test.; Kaur H., Choi H., You Y.N., Rauch G.M., Jensen C.T., Hou P., Chang G.J., Skibber J.M., Ernst R.D. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012; 32 (2): 389–409. http://doi.org/10.1148/rg.322115122Test; Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone a prospective, multicenter, european study. Ann. Surg. 2011; 253 (4): 711–719. http://doi.org/10.1097/SLA.0b013e31820b8d52Test.; Benson A.B. 3rd, Venook A.P., Al-Hawary M.M., Cederquist L., Chen Y.-J., Ciombor K.K., Cohen S., Cooper H.S., Deming D., Engstrom P.F., Grem J.L., Grothey A., Hochster H.S., Hoffe S., Hunt S., Kamel A., Kirilcuk N., Krishnamurthi S., Messersmith W.A., Meyerhardt J., Mulcahy M.F., Murphy J.D., Nurkin S., Saltz L., Sharma S., Shibata D., Skibber J.M., Sofocleous C.T., Stoffel E.M., Stotsky-Himelfarb E., Willett C.G., Wuthrick E., Gregory K.M., Gurski L., Freedman-Cass D.A. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. (JNCCN). 2018; 16 (7): 874–901. http://doi.org/10.6004/jnccn.2018.0061Test.; Al-Sukhni E., Milot L., Fruitman M., Brown G., Schmocker S., Kennedy E. User’s Guide for the Synoptic MRI Report for Rectal Cancer. Cancer Care Ontario. Canadian Cancer Society. Available at: http://www.osumcradiologyTest. org/resources/High-Yield-Rad-info/Rectal-MRI.pdf (accessed August 12, 2018). (In Russian).; Moran M.R., James E.C., Rothenberger D.A., Goldberg S.M. Prognostic value of positive lymph-nodes in rectal-cancer. Dis. Colon. Rectum. 1992; 35 (6): 579–581.; Quirke P., Williams G. Minimum dataset for colorectal cancer histopathology reports. London: Royal College of Pathologists, 2000.; Bipat S., Glas A.S., Slors F.J.M., Zwinderman A.H., Bossuyt P.M.M., Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging – A meta-analysis. Radiology. 2004; 232 (3): 773–783. http://doi.org/10.1148/radiol.2323031368Test.; Schnall M.D., Furth P.E.E., Rosato E.F., Kressel H.Y. Rectal tumor stage – correlation of endorectal MR-imaging and pathological findings. Radiology. 1994; 190 (3): 709–714. http://doi.org/10.1148/radiology.190.3.8115616Test.; Brown G., Richards C.J., Bourne M.W., Newcombe R.G., Radcliffe A.G., Dallimore N.S., Williams G.T. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histo pathologic comparison. Radiology. 2003; 227 (2): 371–377. http://doi.org/10.1148/radiol.2272011747Test.; Kotanagi H., Fukuoka T., Shibata Y., Yoshioka T., Aizawa O., Saito Y., Tur G.E., Koyama K. The size of regional lymphnodes does not correlate with the presence or absence of metastasis in lymph-nodes in rectal-cancer. J. Surg. Oncol. 1993; 54 (4): 252–254.; Markl B., Rossle J., Arnholdt H.M., Schaller T., Krammer I., Cacchi C., Jahnig H., Schenkirsch G., Spatz H., Anthuber M. The clinical significance of lymph node size in colon cancer. Mod. Pathol. 2012; 25 (10): 1413–1422. http://doi.org/10.1038/modpathol.2012.92Test.; Smith N.J., Shihab O., Arnaout A., Swift R.I., Brown G. MRI for detection of extramural vascular invasion in rectal cancer. Am. J. Roentgenol. 2008; 191 (5): 1517–1522. http://doi.org/10.2214/AJR.08.1298Test.; Chand M., Swift R.I., Tekkis P.P., Chau I., Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br. J. Cancer. 2014; 110 (1): 19–25. http://doi.org/10.1038/bjc.2013.603Test.; Chand M., Evans J., Swift R.I., Tekkis P.P., West N.P., Stamp G., Heald R.J., Brown G. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann. Surg. 2015; 261 (3): 473–479. http://doi.org/10.1097/SLA.0000000000000848Test.; Faes S., Gie O., Demartines N., Hahnloser D. Multidisciplinary treatment of locally advanced rectal cancer. Rev. Med. Suisse. 2016; 12 (523): 1185–1189. (In French); Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. The Lancet. 1908; 172 (4451): 1812–1813.; Heald R.J. The holy plane of rectal surgery. J. R. Soc. Med. 1988; 81 (9): 503–508. PMID: 3184105.; Heald R.J., Moran B.J., Ryall R.D.H., Sexton R., MacFarlane J.K. Rectal cancer – the basingstoke experience of total mesorectal excision, 1978–1997. Arch. Surg. 1998; 133 (8): 894–898.; Quirke P., Dixon M.F., Durdey P., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection – histopathological study of lateral tumor spread and surgical excision. Lancet. 1986; 2 (8514): 996–999.; Taylor F.G.M., Quirke P., Heald R.J., Moran B.J., Blomqvist L., Swift I.R., Sebag-Montefiore D., Tekkis P., Brown G. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year followup results of the MERCURY study. J. Clin. Oncol. 2014; 32 (1): 34–114. http://doi.org/10.1200/JCO.2012.45.3258Test.; Bown E.J., Lloyd G.M., Boyle KM., Miller A.S. Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery. Int. J. Colorectal. Dis. 2014; 29 (2): 147–155. http://doi.org/10.1007/s00384-013-1772-zTest.; Zhao J., Du C.Z., Sun Y.S., Gu J. Patterns and prognosis of locally recurrent rectal cancer following multi disciplinary treatment. Wld J. Gastroenterol. 2012; 18 (47): 7015–7020. http://doi.org/10.3748/wjg.v18.i47.7015Test.; Purkayastha S., Tekkis P.P., Athanasiou T., Tilney H.S., Darzi A.W., Heriot A.G. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis. 2007; 9 (5): 402–411. http://doi.org/10.1111/j.1463-1318.2006.01104.xTest.; Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., St Rose S., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br. J. Surg. 2011; 98 (6): 872–879. DOI:10.1002/bjs.7458.; Rullier E., Denost Q., Vendrely V., Rullier A., Laurent C. Low rectal cancer: classification and standardization of surgery. Dis. Colon. Rectum. 2013; 56 (5): 560–567. http://doi.org/10.1097/DCR.0b013e31827c4a8cTest.; Perez R., Habr-Gama A., Camargo A., Souza S., Parmigiani R., Galante P., Salim A., Souza J., Quevedo B., Felicio N., Gama-Rodrigues J. Prediction of response to neoadjuvant chemoradiation therapy in patients with distal rectal cancer by gene expression using last generation sequencing. Dis. Colon. Rectum. 2011; 54 (5): Е7–E7.; Черниковский И.Л. Мультидисциплинарный подход в диагностике и лечении резектабельного рака прямой кишки. Практическая онкология. 2015; 16 (2): 69–76.; Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., Karstens J.H., Liersch T., Schmidberger H., Raab R., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl. J. Med. 2004; 351 (17): 1731–1740. http://doi.org/10.1056/NEJMoa040694Test.; Hotker A.M., Tarlinton L., Mazaheri Y., Woo K.M., Gonen M., Saltz L.B., Goodman K.A., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemo radiotherapy: A comparison of morphological, volumetric and functional MRI parameters. Eur. Radiol. 2016; 26 (12): 4303–4312. http://doi.org/10.1007/s00330-016-4283-9Test.; Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 1997; 12 (1): 19–23.; Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., Cottone M. Preoperative radiotherapy for resectable rectal cancer – a meta-analysis. J. Am. Med. Ass. 2000; 284 (8): 1008–1015.; Bhangu A., Ali S.M., Cunningham D., Brown G., Tekkis P. Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis. 2013; 15 (2): 156–163. http://doi.org/10.1111/j.1463-1318.2012.03123.xTest.; Тюряева Е.И. Химиолучевое лечение рака прямой кишки. Практическая онкология. 2008; 9 (1): 31–38.; Keam S.J., Dunn C.J., Figgitt D.P. Oxaliplatin – in operable colorectal cancer. Drugs. 2005; 65 (1): 89–96. http://doi.org/10.2165/00003495-200565010-00005Test.; Hoetker A.M., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI of rectal cancer in the assessment of response to therapy: a systematic review. Dis. Colon Rectum. 2014; 57 (6): 790–799. http://doi.org/10.1097/DCR.0000000000000127Test.; Evans J., Tait D., Swift I., Pennert K., Tekkis P., Wotherspoon A., Chau I., Cunningham D., Brown G. Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Dis. Colon Rectum. 2011; 54 (10): 1251–1259. http://doi.org/10.1097/DCR.0b013e3182281f4bTest.; Patel U.B., Brown G., Rutten H., West N., SebagMontefiore D., Glynne-Jones R., Rullier E., Peeters M., Van Cutsem E., Ricci S., Van de Velde C., Kjell P., Quirke P. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann. Surg. Oncol. 2012; 19 (9): 2842–2852. http://doi.org/10.1245/s10434-012-2309-3Test.; Patel U.B., Brown G. MRI-based assessment of tumor regression in rectal cancer. Curr. Colorectal Cancer Rep. 2013; 9 (2): 136–145. http://doi.org/10.1007/s11888-013-0169-2Test.; Sassen S., de Booij M., Sosef M., Berendsen R., Lammering G., Clarijs R., Bakker M., Beets-Tan R., Warmerdam F., Vliegen R. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur. Radiol. 2013; 23 (12): 3440–3449. http://doi.org/10.1007/s00330-013-2956-1Test.; Park M.J., Kim S.H., Lee S.J., Jang K.M., Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011; 260 (3): 771–780. http://doi.org/10.1148/radiol.11102135Test.; Boone D., Taylor S.A., Halligan S. Diffusion weighted MRI: overview and implications for rectal cancer management. Colorectal Dis. 2013; 15 (6): 655–661. http://doi.org/10.1111/codi.12241Test.; Heijnen L.A., Lambregts D.M.J., Mondal D., Martens M.H., Riedl R.G., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur. Radiol. 2013; 23 (12): 3354–3360. http://doi.org/10.1007/s00330-013-2952-5Test.; Alberda W.J., Dassen H.P.N., Dwarkasing R.S., Willemssen F.E.J.A., van der Pool A.E.M., de Wilt J.H.W., Burger J.W. A., Verhoef C. Prediction of tumor stage and lymph node involvement with dynamic contrastenhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int. J. Colorectal Dis. 2013; 28 (4): 573–580. http://doi.org/10.1007/s00384-012-1576-6Test.; Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J. Clin. Oncol. 2006; 24 (20): 3293–3298. http://doi.org/10.1200/JCO.2006.06.8080Test.; Fusco R., Sansone M., Petrillo M., Avallone A., Delrio P., Petrillo A. Dynamic Contrast Enhanced Magnetic Resonance Imaging in Rectal Cancer. Rectal Cancer-A Multidisciplinary Approach to Management / Giulio D., Santoro A. InTech. 2011; 75–98.; Arya S., Das D., Engineer R., Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J. Radiol. Imaging. 2015; 25 (2): 148–161. http://doi.org/10.4103/0971-3026.155865Test.; https://medvis.vidar.ru/jour/article/view/766Test